Samir Patel
Vermögen: 63 473 $ am 31.05.2025
Vermögen: 63 473 $ am 31.05.2025
Dr. Samir R.
Patel, MD, is a President & Secretary at Peak Bio, Inc., a Chief Executive Officer at Digital Therapeutics LLC, a President, Secretary & Director at Pegasus Merger Sub, Inc., a Principal at Pranabio Investments LLC and a Principal at SPEC Pharma LLC.
He is on the Board of Directors at Akari Therapeutics Plc and Pegasus Merger Sub, Inc. Dr. Patel was previously employed as an Independent Director by CytoDyn, Inc., an Independent Director by Rezolute, Inc., and a Medical Affairs by Centocor, Inc. He received his undergraduate degree from the University of Cincinnati (Ohio) and a doctorate degree from the University of Toledo Medical Center.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AKARI THERAPEUTICS PLC 11,93 % | 01.06.2026 | 6.347.346.000 ( 11,93 % ) | 63 473 $ | 31.05.2025 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Direktor/Vorstandsmitglied | 29.11.2023 |
| PEAK BIO, INC. | Präsident | 14.11.2024 |
SPEC Pharma LLC
SPEC Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which specializes in injectable therapies | Gründer | - |
Digital Therapeutics LLC
Digital Therapeutics LLC Packaged SoftwareTechnology Services Develops application for personalized and gamified cognitive behavioral therapy to smokers trying to quit | Vorstandsvorsitzender | 01.08.2011 |
Pranabio Investments LLC
Pranabio Investments LLC Financial ConglomeratesFinance Provides investment services | Gründer | - |
Pegasus Merger Sub, Inc. | Präsident | - |
| Unternehmen | Position | Ende |
|---|---|---|
| CYTODYN INC. | Direktor/Vorstandsmitglied | 28.10.2021 |
| REZOLUTE, INC. | Direktor/Vorstandsmitglied | 10.02.2019 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
CytoDyn, Inc.
CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Cincinnati (Ohio)
University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo Medical Center
University of Toledo Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Pranabio Investments LLC
Pranabio Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
SPEC Pharma LLC
SPEC Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which specializes in injectable therapies | Health Technology |
Digital Therapeutics LLC
Digital Therapeutics LLC Packaged SoftwareTechnology Services Develops application for personalized and gamified cognitive behavioral therapy to smokers trying to quit | Technology Services |
Peak Bio, Inc.
Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
Pegasus Merger Sub, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen